Why haven’t the company released the much referenced (every PR) already received anti-viral results from the RBL? I think shareholders deserve to know and not be teased. The company was not shy in releasing similar Covid data? You can’t tease that the company is now an antiviral company and not put any evidence behind it. And does this also presume should the Covid trial fail to meet its primary endpoint, that the entire antiviral program is dead...? Dont shareholders deserve to know the already conducted antiviral data and wouldn’t that released give a much needed shot in the arm “enthusiasm” at .21? Even the most rabid promoters of the stock on this board would probably agree that they would love to see a press release today touting the amazing antiviral efficacy against other viruses.
Market Data 
Markets 
AI
